Erythropoietin Stimulating Agents & IV Iron
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)contractFind a Tender ↗Ref ocds-h6vhtk-03bf2232014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
5
Lots
1
5 awarded
Published
01 Sept 2023
Description
Erythropoietin Stimulating Agents & IV Iron
Scope
- Reference
- PAD-OJEU-52670
- Commercial tool
- Standalone contract
- Contract dates
- 30 Sept 2023 to 30 Sept 2025
There is a possibility to extend up to a further 24 months
- Main category
- goods
- Contract locations
- Wales
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Ability to meet the Contract Specification | Pass/Fail | quality | — |
| Product Quality/Acceptability | Pass/Fail | quality | — |
| Financial (overall cost of contract) | 50 | quality | — |
| Social Value/Community Benefits | 15 | quality | — |
| Price | 40 | cost | — |
| Price stability | 10 | cost | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 5 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Award 1· 1 supplier
Awarded —
Award value
—
Award 2· 1 supplier
Awarded —
Award value
—
Award 3· 1 supplier
Awarded —
Award value
—
Award 4· 1 supplier
Awarded —
Award value
—
Award 5· 1 supplier
Awarded —
Award value
—
Other contracts from Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Amgen Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Ustekinumab | contract | — | 15 Jun 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| Transitional Drugs 7 | contract | — | 05 Jun 2026 |
| Transitional Drugs 6 | contract | — | 30 Mar 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 19 Dec 2025 |
| NHS National Framework for Denosumab Injection commencing 1st January 2026 | contract | — | 04 Dec 2025 |
| Project/Contract NHS National Framework for Denosumab Injection | contract | — | 02 Oct 2025 |
| Romiplostim (Nplate®) | contract | — | 10 Sept 2025 |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | contract | £47.0m | 29 Jul 2025 |